N.J. Admin. Code § 8:31B-4.89

Current through Register Vol. 56, No. 11, June 3, 2024

Section 8:31B-4.89 - Drugs Sold to Patients (DRU)

(a) Function:

1. The Drugs Sold to Patients center is used for the accumulation of the invoice cost and corresponding revenue of all pharmaceuticals and intravenous solutions individually charged to patients including chemotherapy drugs. The invoice/inventory cost of non-charged (pharmaceuticals) or I.V. solutions issued by the Pharmacy to other centers shall be transferred to the using centers, preferably on a monthly basis. If such items are sold in other centers, the cost of those items must be transferred to this center. The overhead cost of preparing and issuing drugs and I.V. solutions sold directly to patients must be accumulated in the Pharmacy center.

2. Medically prescribed food supplements, if charged directly to patients are included in Drugs Sold to Patients. Cost and revenue associated with blood (that is, whole blood and packed red cells) and blood components (that is, fibrinogen, gamma globulin) are to be excluded from the Laboratory center and reported as a reconciliation per N.J.A.C. 8:31B-4 and 8:31B-4.91. Excluded from this center are the cost and revenue associated with drugs furnished to a patient for use after his episode of hospital care (except for those items where it would be medically unreasonable to limit the patient's use to the episode of hospital care). Included in the center are the cost and revenue associated with drugs and I.V. solutions sold under renal dialysis and home health agency programs as specified in Medicare Provider Reimbursement Manual, Publication 15, Part II, Chapter 36, Hospital and Hospital Heath Care Complex Cost Report, incorporated herein by reference and available at www.CMS.hhs.gov/manuals/cmsindex.asp.

N.J. Admin. Code § 8:31B-4.89

Amended by R.1995 d.507, effective 9/5/1995.
See: 27 New Jersey Register 2148(a), 27 New Jersey Register 3481(a).
Amended by R.2006 d.27, effective 1/17/2006.
See: 37 New Jersey Register 2165(a), 38 New Jersey Register 667(a).
In (a)2, substituted "that is" for "i.e.", deleted reference to HIM-29 and HIM-11 and Part IV, and added the address to the Medicare website.